Add BrightSurf on Google Email

Chinese Neurosurgical Journal study updates guidelines for prolactinoma care

A multidisciplinary consensus updates treatment guidance for prolactinomas, emphasizing early recognition, individualized management strategies, and advanced imaging. The recommendations cover screening, assessment, diagnosis, treatment, and long-term monitoring to improve patient outcomes and quality of life.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateJul 13, 2026

ESE and ESPE launch joint transition of care guidance to improve outcomes for young people moving from child to adult endocrine care

The ESE and ESPE have launched a landmark Joint Clinical Practice Guidance to support structured and effective transition of young people with endocrine conditions. The Guidance provides practical, evidence-based recommendations to ensure continuity, safety and quality of care during this critical phase in a patient's life.

A systematic review organises available omics data on pituitary tumours

A recent systematic review has compiled and catalogued publicly available omics data on pituitary tumours, highlighting the need for standardisation and clinical annotation. The resulting catalogue facilitates the reuse of data for future research projects and precision medicine initiatives.

SourceGermans Trias i Pujol Research Institute·JournalMachine Learning and Knowledge Extraction·TypeSystematic review·DateFeb 2, 2026

Yearly re-scanning not needed for common brain tumor detected in 1 in 10 people

A UK-wide study found that non-functioning pituitary microadenomas (NFPA) are more likely to shrink or disappear than grow within three years of monitoring. The study suggests that clinical guidelines should be changed, and a single scan three years after initial detection would be a safe and cost-effective way to manage NFPAs.

SourceUniversity of Birmingham·JournalEuropean Journal of Endocrinology·TypeData/statistical analysis·DateJun 23, 2023

Purified pituitary tissue generated from stem cells

Scientists have successfully converted human pluripotent stem cells into purified pituitary cells that secrete adrenocorticotropic hormone (ACTH), a hormone normally produced by the pituitary gland. Transplantation of these cells into mice with hypopituitarism resulted in long-lasting improvement in ACTH levels.

SourceCell Press·JournalStem Cell Reports·TypeExperimental study·DateJun 8, 2023

Narrowing in on pituitary tumors

Researchers at Brigham and Women's Hospital have developed a new technique to analyze specific hormones in tissue, allowing surgeons to distinguish tumor from normal gland. The technique, called MALDI MSI, can determine hormone composition in under 30 minutes, potentially improving surgical precision.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·DateJul 27, 2015

New cause of thyroid hormone deficiency discovered

Researchers at McGill University have identified a new hereditary form of hypothyroidism caused by mutations in the immunoglobulin superfamily, member 1 (IGSF1) gene. This sex-biased condition affects males more frequently than females and has significant implications for thyroid hormone deficiency diagnosis and treatment.

SourceMcGill University·JournalNature Genetics·DateNov 12, 2012